Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
24.88
+1.27 (5.38%)
At close: Sep 2, 2026, 4:00 PM EDT
24.91
+0.03 (0.12%)
After-hours: Sep 2, 2026, 4:10 PM EDT

Seaport Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
1,332--
Market Cap Growth
---
Enterprise Value
1,064--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Debt / Equity Ratio
0.010.020.02
Net Debt / Equity Ratio
-0.63-0.91-1.01
Net Debt / EBITDA Ratio
1.872.485.82
Net Debt / FCF Ratio
3.022.6910.22
Quick Ratio
17.7517.1327.72
Current Ratio
18.0017.4627.82
Return on Equity (ROE)
--28.08%-
Return on Assets (ROA)
--18.90%-
Return on Capital Employed (ROCE)
-33.80%-36.10%-17.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Buyback Yield / Dilution
--151.76%-
SEC Filings: 10-K · 10-Q